Speeding up clinical trials by making drug production local

The Boston area has long been home to innovation that leads to impactful new drugs. But manufacturing those drugs for clinical trials often involves international partners and supply chains. The vulnerabilities of that system have become all too apparent during the Covid-19 pandemic.

Now Snapdragon Chemistry, co-founded by MIT Professor and Associate Provost Tim Jamison, is helping pharmaceutical companies manufacture drugs locally to shorten the time it takes for new drugs to get to patients.

Snapdragon essentially starts as a chemistry lab, running experiments on behalf of pharmaceutical customers to create molecules of interest. From there it seeks to automate production processes, often lessening the number of steps it takes to create those molecules. Sometimes the new process will require a technology — such as a specialized chemical reactor — the client doesn’t have, so Snapdragon builds the equipment for the client and teaches them to incorporate it into their…
Click here to view original post